ACDM

YYC Calgary International Airport Begins Use of Deice Metering Program Powered by Passur ARiVA™ Solutions

Retrieved on: 
화요일, 11월 29, 2022
OTC, Partnership, ACDM, News, Airport Collaborative Decision Making, Praboo Ariva, Airline, Satellite navigation device, Risk management, YYC

ORLANDO, Fla., Nov. 29, 2022 /PRNewswire/ -- PASSUR Aerospace, Inc. (PASSUR) announced that it has successfully deployed its ARiVA™ Platform (ARiVA) Deice Metering Program for use by YYC Calgary International Airport, to ensure optimal alignment of flight demand and capacity during deice events, when restricted operations can often lead to delays and other disruptions.  

Key Points: 
  • In addition to the Deice Metering Program, ARiVA also offers airfield workflow optimization modules for single-screen collaboration between all Airport stakeholders for tows, ramp movements, and gate management.
  • "We are honored that Calgary has chosen ARiVA to meet this critical need for the Airport and its stakeholders," said Brian Cook, PASSUR Aerospace CEO.
  • PASSUR and YYC were able to quickly deploy the ARiVA Deice Metering system in a matter of weeks for use during the YYC 2022-2023 deicing season.
  • PASSUR provides its solutions to the largest airlines and airports globally including in the United States, Canada, and Latin America.

PTC Therapeutics' 2022 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community

Retrieved on: 
수요일, 9월 7, 2022
Muscle weakness, Therapy, Muscle, PTC, Program, Degenerative disease, NASDAQ, Awareness, Time, Dystrophin, Dystrophy, Diaphragm, National Eating Disorders Association, Disease, Human, Heart, Muscular Dystrophy Association, LinkedIn, Duchenne muscular dystrophy, Diagnosis, Binary relation, Education, Organization, Student, Patient, ACDM, PTC Therapeutics, Company, Twitter, Association, Cohesion (linguistics), Knowledge, Death, Medicine, Tutoring, Pharmaceutical industry, U.K, Empowerment, Duchenne, Facebook

SOUTH PLAINFIELD, N.J., Sept. 7, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the four recipients of its 2022 STRIVE Awards for Duchenne Muscular Dystrophy. The STRIVE program provides grants to non-profit patient advocacy organizations serving the Duchenne community. This year, grants will fund projects focused on formal learning, psychological support, sexuality, and skills-based training for people with Duchenne.  

Key Points: 
  • The STRIVE program provides grants to non-profit patient advocacy organizations serving the Duchenne community.
  • "We are proud to support the 2022 grant recipients for their work in the Duchenne community through our STRIVE Awards program.
  • They have shown the broad range of needs in the Duchenne community, including programs supporting adults living with Duchenne,"said Mary Frances Harmon, senior vice president, Corporate Relations, PTC Therapeutics.
  • PTC launched the Strategies to Realize Innovation, Vision, and Empowerment (STRIVE) Awards program in 2015 to support initiatives that benefit the Duchenne community by increasing awareness, diagnosis, and education, and fostering the development of future patient advocates.

Medrio Proudly Joins Association for Clinical Data Management (ACDM)

Retrieved on: 
월요일, 3월 14, 2022
Ecosystem, Solution, Clinical data management, Environment, Leadership, AstraZeneca, Data management, ACDM, EDC, Cros, EPRO, Management, Pharmaceutical industry, Medicine

"Medrio is proud to align with an organization that is equally as enthusiastic about improving the drug development process through contemporary Clinical Data Management practices," says Nicole Latimer, Chief Executive Officer at Medrio.

Key Points: 
  • "Medrio is proud to align with an organization that is equally as enthusiastic about improving the drug development process through contemporary Clinical Data Management practices," says Nicole Latimer, Chief Executive Officer at Medrio.
  • "We hold ourselves to the strictest standards and regulations when it comes to data management, and we look forward to collaborating with fellow data management experts on how to maintain and improve industry standards."
  • "We are excited for Medrio to collaborate, constructively engage, and share experiences that support the continuous improvement of Clinical Data Management practices.
  • ACDM represents enthusiastic clinical research professionals with a passion to improve the drug development process by offering an environment for continuous learning and application of contemporary Clinical Data Management practices.

eClinical Solutions to Showcase How Modern Data Infrastructure and Analytics Platform Delivers Streamlined Drug Development Operations at SCOPE, OCT West and ACDM

Retrieved on: 
월요일, 2월 7, 2022
Cloud, Convergence, Growth, SCOPE, Science 37, Conference, Automation, Solution, Association, OCT, Therapy, Efficiency, Data management, CDR, Gubb, Cros, Science, CEO, Monitoring, Port Curtis Co-operative Dairy Association Ltd Factory, Organization, Drug development, ACDM, Q&A, MDR, Summit, Pharmaceutical industry, Clinical data management

"There has never been a more critical time to innovate and speed clinical trial processes by rethinking how we manage disparate and complex clinical data.

Key Points: 
  • "There has never been a more critical time to innovate and speed clinical trial processes by rethinking how we manage disparate and complex clinical data.
  • Following SCOPE, eClinical Solutions will attend and exhibit at Outsourcing in Clinical Trials (OCT) West Coast (February 15-16).
  • eClinical's expanded west coast team will be in OCT West booth #81 showcasing how the elluminate Clinical Data Cloud supports operating model flexibility without sacrificing control.
  • eClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives with modern data infrastructure and analytics.